Exelixis (EXEL) Other Non-Current Assets (2010 - 2022)

Exelixis (EXEL) recorded quarterly Other Non-Current Assets of $280.0 million in Q3 2022, little changed quarter-over-quarter from $279.7 million in Q3 2022, and up 107.91% on a YoY basis from $134.7 million in Q3 2021.

Exelixis (EXEL) Other Non-Current Assets (2010 - 2022) Analysis & Trends

Exelixis' Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $280.0 million for Q3 2022.

  • In Q3 2022, Other Non-Current Assets rose 107.91% year-over-year to $280.0 million; the TTM figure through Sep 2022 stood at $280.0 million (up 107.91% YoY), while the FY2021 annual figure was $131.0 million, up 78.46% from the prior year.
  • Other Non-Current Assets was $280.0 million for Q3 2022 at Exelixis, roughly flat from $279.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $280.0 million in Q3 2022 to a low of $1.0 million in Q3 2019.
  • Historically, Other Non-Current Assets has averaged $81.7 million across 5 years, with a median of $60.5 million in 2020.
  • The sharpest annual moves came in 2019 and 2020: Other Non-Current Assets declined 26.67% in 2019, then soared 6840.9% in 2020.
  • A 5-year view of Other Non-Current Assets shows it stood at $8.3 million in 2018, then slumped by 87.94% to $1.0 million in 2019, then jumped by 6840.9% to $69.4 million in 2020, then surged by 88.74% to $131.0 million in 2021, then jumped by 113.74% to $280.0 million in 2022.
  • The last three Other Non-Current Assets figures came in at $280.0 million (Q3 2022), $279.7 million (Q3 2022), and $139.0 million (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 60,000.00
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1.26 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 280.01 Mn
Jul 1, 2022 279.71 Mn
Apr 1, 2022 138.99 Mn
Dec 31, 2021 131.00 Mn
Oct 1, 2021 134.68 Mn
Jul 2, 2021 134.93 Mn
Apr 2, 2021 124.68 Mn
Jan 1, 2021 73.41 Mn
Oct 2, 2020 69.41 Mn
Jul 3, 2020 60.50 Mn
Apr 3, 2020 57.31 Mn
Jan 3, 2020 53.15 Mn
Sep 27, 2019 1.00 Mn
Jun 28, 2019 1.10 Mn
Mar 29, 2019 1.10 Mn
Dec 28, 2018 8.29 Mn
Sep 28, 2018 1.10 Mn
Jun 29, 2018 1.10 Mn
Mar 30, 2018 1.50 Mn
Dec 29, 2017 4.65 Mn